Mealey's (September 20, 2018, 8:10 AM EDT) -- WASHINGTON, D.C. — A federal judge in the District of Columbia on Sept. 12 dismissed in part claims brought by a former laboratory director accusing a company of violating the False Claims Act (FCA) and Anti-Kickback Statute (AKS) when submitting claims to Medicare for lipid screening tests, finding that he did not sufficiently allege that the company could be liable for self-referrals, charging speaker fees for a doctor and nurse practitioner and submitting claims for medically unnecessary tests (United States, ex rel. Chris Riedel v. Boston Heart Diagnostics Corp., No. 12-1423, D. D.C., 2018 U.S. Dist. LEXIS 155113)....